Deadly Trait Combo Arms German E. coli

The virulent strain that has killed 48 people produces Shiga toxin and sticks to the intestinal wall.

By | June 27, 2011


The deadly E. coli outbreak that swept Germany in May was caused by a virulent strain of the bacteria that produces Shiga toxin and is able to stick to the intestinal wall in a brick-like clumping pattern, according to two papers published last week. “Once you see it you will never forget it,” Helge Karch of the University of Münster, senior author of a paper in the Lancet Infectious Diseases, told the New York Times. The virulent strain caused haemolytic uraemic syndrome (HUS)–a blood clotting disease that leads to kidney failure–in 25 percent of the patients, a much larger percentage than previous outbreaks of Shiga-toxin–producing E. coli, suggesting that this strain is exceptionally virulent, a paper in the New England Journal of Medicine reported.

Other researchers argue there is not enough evidence to conclude the strain is particularly virulent. "In every outbreak we don't ascertain some mild cases, and in this one there's a large potential for underascertainment of a very large number of more mildly affected cases," Kirk Smith, supervisor of the Foodborne Disease Unit at the Minnesota Department of Health told CIDRAP News. So the high number of deaths may be attributable to an unusually widespread outbreak, not exceptional virulence.

In Germany, the daily numbers of reported cases have steadily decreased since they peaked on May 22, the World Health Organization reported today (June 27). To date, the outbreak has caused a total of 3,920 infections, including 48 fatalities.


Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.